 Influenza, Human
"Influenza, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
| Descriptor ID |
D007251
|
| MeSH Number(s) |
C02.782.620.365 C08.730.310
|
| Concept/Terms |
Influenza, Human- Influenza, Human
- Human Influenzas
- Influenzas, Human
- Influenza
- Influenzas
- Human Flu
- Flu, Human
- Human Influenza
- Influenza in Humans
- Influenza in Human
- Grippe
|
Below are MeSH descriptors whose meaning is more general than "Influenza, Human".
Below are MeSH descriptors whose meaning is more specific than "Influenza, Human".
This graph shows the total number of publications written about "Influenza, Human" by people in this website by year, and whether "Influenza, Human" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 2000 | 0 | 1 | 1 | | 2001 | 1 | 1 | 2 | | 2005 | 6 | 0 | 6 | | 2006 | 5 | 2 | 7 | | 2007 | 6 | 3 | 9 | | 2008 | 1 | 0 | 1 | | 2009 | 10 | 0 | 10 | | 2010 | 19 | 1 | 20 | | 2011 | 24 | 0 | 24 | | 2012 | 15 | 2 | 17 | | 2013 | 5 | 4 | 9 | | 2014 | 13 | 0 | 13 | | 2015 | 11 | 1 | 12 | | 2016 | 10 | 4 | 14 | | 2017 | 17 | 7 | 24 | | 2018 | 17 | 2 | 19 | | 2019 | 20 | 2 | 22 | | 2020 | 25 | 5 | 30 | | 2021 | 23 | 5 | 28 | | 2022 | 29 | 0 | 29 | | 2023 | 20 | 1 | 21 | | 2024 | 23 | 3 | 26 | | 2025 | 23 | 3 | 26 | | 2026 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Influenza, Human" by people in Profiles.
-
Campbell AJ, Shephard M, Paulos AP, Pauly MD, Vu MN, Stenkamp-Strahm C, Bushfield K, Hunter-Binns B, Sablon O, Bendall EE, Fitzimmons WJ, Brizuela K, Quirk GE, Kumar N, McCluskey B, Shetty N, Marr LC, Guthmiller JJ, Santos JJS, Hensley SE, Marshall ES, Abernathy K, Lauring AS, Melody BT, Wolfe MK, Lombard J, Lakdawala SS. Surveillance on California dairy farms reveals multiple possible sources of H5N1 influenza virus transmission. PLoS Biol. 2026 May; 24(5):e3003761.
-
Krupinsky KC, Bendall EE, Zhu Y, Stockwell MS, Nguyen HQ, Meece JK, Maldonado Y, Ellingson KD, Lutrick K, Asturias EJ, Rao S, Bowman NM, Rolfes M, Biddle JE, Mellis A, Schmitz JE, Chappell JD, Halasa NB, Fitzsimmons WJ, Martin ET, Grijalva CG, Talbot HK, Lauring AS. The impact of viral and host factors on the influenza A virus transmission bottleneck. PLoS Pathog. 2026 03; 22(3):e1014079.
-
Maloney P, Reeves EL, Wielgosz K, Price AM, Natarajan K, DeSilva MB, Dascomb K, Klein NP, Tartof SY, Irving SA, Grannis SJ, Ong TC, Weber ZA, Schuster JE, Zerr DM, Michaels MG, Boom JA, Halasa NB, Staat MA, Weinberg GA, House SL, Saade EA, Geffel KM, Gaglani M, Wernli KJ, Murugan V, Martin ET, Bontrager NAB, Kirby MK, Payne AB, Dawood FS, Tannis A, Moline HL, Zhao SK, Adams K, DeCuir J, Olson SM, Chung JR, Lewis N, Flannery B, Reed C, Garg S, Ellington S. Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026. MMWR Morb Mortal Wkly Rep. 2026 Mar 12; 75(9):116-123.
-
Harker EJ, Lewis NM, Johnson CA, Zhu Y, Self WH, Halasa N, Chappell JD, Grijalva CG, Safdar B, Gaglani M, Columbus C, Steingrub J, Shapiro N, Duggal A, Busse L, Giles L, Peltan I, Hager D, Mohamed A, Exline M, Khan A, Tam GK, Qadir N, Mosier J, Ginde A, Mohr N, Mallow C, Leis A, Lauring A, Harris E, Johnson N, Gibbs K, Kwon J, Surie D, Dawood FS, Ellington S. Differences in influenza vaccine effectiveness by sex among adults hospitalized with acute respiratory illness-IVY network, January 24, 2022-September 1, 2024. Vaccine. 2026 Feb 27; 74:128192.
-
Williams JTB, Kurlandsky K, Stein AB, Bharadwaj N, Hambidge SJ, Pereira RI, O'Leary SC, Johnson D, O'Leary ST. Narrative Reminder Recall to Improve Pediatric Influenza Vaccination: A Pilot Randomized Clinical Trial. JAMA Netw Open. 2026 Jan 02; 9(1):e2552149.
-
Zhang Z, Uribe I, Davis KA, McPherson RL, Larson GP, Badiee M, Tran V, Ledwith MP, Feltman EM, Yú S, Caì Y, Chang CY, Yang X, Ma Z, Chang P, Kuhn JH, Leung AKL, Mehle A. Global remodeling of ADP-ribosylation by PARP1 suppresses influenza A virus infection. Nat Commun. 2025 Dec 17; 16(1):11176.
-
Adams K, Garg S, Tartof SY, Irving SA, DeSilva MB, Klein NP, Natarajan K, Dascomb K, Grannis SJ, Ong TC, Salas SB, Sy LS, Lewin B, Qian L, Naleway AL, Koppolu PD, McEvoy CE, Akinsete O, Essien I, Fireman B, Zerbo O, Jacobson KB, Timbol J, Neelam V, Reeves EL, Dickerson M, Ray C, Link-Gelles R, Mak J, Ball SW, O'Reilly M, Olsen SJ, Tenforde MW. Patterns in Prescribing and Dispensing Influenza Antivirals Among Adults With Influenza Presenting to Urgent Care and Emergency Department Settings: VISION Network, 2023-2024. Clin Infect Dis. 2025 Nov 06; 81(4):e172-e183.
-
Pasco R, Hayden FG, Meyers LA. Modeling Influenza Antiviral Strategies: Reducing Burden and Preventing Resistance. J Infect Dis. 2025 Oct 17; 232(Supplement_3):S299-S308.
-
Frutos AM, Tenforde MW, Sundaresan D, Naleway AL, Irving SA, DeSilva MB, Kharbanda AB, Ong TC, Rao S, Zheng K, Gohil SK, Ball SW, Fink RV, Reed C, Garg S, Bozio CH. Influenza-Associated Hospitalization Rates by Underlying Conditions, 2016-2017 to 2019-2020: A Retrospective Cohort Study. J Infect Dis. 2025 Oct 15; 232(4):e642-e650.
-
Lewis NM, Harker EJ, Cleary S, Zhu Y, Grijalva CG, Chappell JD, Rhoads JP, Baughman A, Casey JD, Blair PW, Jones ID, Johnson CA, Halasa NB, Lauring AS, Martin ET, Gaglani M, Ghamande S, Columbus C, Steingrub JS, Duggal A, Felzer JR, Prekker ME, Peltan ID, Brown SM, Hager DN, Gong MN, Mohamed A, Exline MC, Khan A, Ferguson SAN, Mosier J, Qadir N, Chang SY, Ginde AA, Zepeski A, Mallow C, Harris ES, Johnson NJ, Gibbs KW, Kwon JH, Vaughn IA, Ramesh M, Safdar B, Surie D, Dawood FS, Ellington S, Self WH. Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024. J Infect Dis. 2025 Oct 15; 232(4):e626-e636.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|